Based on our advanced algorithm, we predict that BLTE stock price will experience significant movement in the coming periods. Our 1-day prediction estimates a price of $59.566, while the 1-week outlook suggests a value of $60.446. For the 1-month forecast, we project a price of $59.649. Looking further ahead, our 2026 projection estimates a value of $0.00, with a long-term 2030 forecast reaching $0.00. Stay informed and make strategic decisions with our data-driven insights!
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. BLTE has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
BLTE stock price ended at $58.63 on Monday, after losing-1.4%
The Belite Bio Inc stock price decreased by -1.4% on the last trading day (07 Jul 2025), dropping from 59.26 to 58.63. Throughout the last trading session, the stock experienced a fluctuation of 2.52% , ranging from a day low of $57.99 to a day high of 59.45. The price has declined in 7 of the last 10 days, resulting in a total change of -3.06% during this period. On the last day, trading volume increase by -4.19K shares, with the falling prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 60.24K shares were traded, amounting to approximately 3.54M.
BLTE Technical Signals
BLTE(Belite Bio Inc Corp) has 0 buy signals and 4 sell signals now. The current trend is uptrend starting from 2025-07-02. The total price change during this trend is +3.20%. Recently, the price has decreased but the volume has also decreased, indicating a potential rebound signal. The average turnover of BLTE over the last 5 trading days is 4.32M. Overall, the technical indicator signals lean more toward a Bearish outlook in the mid-term.
BLTE Moving Average Analysis
Belite Bio Inc's overall moving average trend leans more bearish as of Tuesday, July 8, 2025, with 3 negative signals and 1 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $63.28, and $65.77. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $55.25, and $52.77. A break-down below any of these levels will issue sell signals.
BLTE Short Selling Analysis
The short sale ratio of Belite Bio Inc(BLTE) as of 03 Jul 2025 is 4.57%, dropping from last trading day. With decreasing price from 56.81 to 59.47. The short sell activity indicate that short sellers may be experiencing short cover.
Technical Signal
Technical Signals Summary
Sell
4
Buy
0
Moving Average
Swing
Positive
Stock Price Above SMA_5
Short Term
Negative
SMA_5 Below SMA_20
Mid Term
Negative
SMA_20 Below SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
0 Bullish Signals
0 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
No Data
4 Bearish Signals
4 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
In 2026, Belite Bio Inc (BLTE) is anticipated to change hands in a trading channel between $0.00 and $0.00.
Belite Bio Inc Stock Forecast 2026
BLTE Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Belite Bio Inc(BLTE), our algorithm predicts BLTE's 1-month price at $61.00, with an 2.58%upwardshift. Using a similarity score up to 94.40%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Belite Bio Inc (BLTE.O) stock, as of Sunday, July 6, 2025 , forecasts a 2.58% change over the next month, based on its high correlation with MFH.O stock patterns. The similarity between their price movements over the analyzed periods is 94.4%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
BLTE
No Data
MFH
Up: 2.58%Similarity: 94.4%
Name
Similarity
Up/Down
MFH.O
94.40%
+2.58%
MANH.O
93.68%
+6.64%
INLX.A
93.23%
+50.00%
NOA.N
92.80%
-14.97%
TBBK.O
92.24%
+19.78%
MXL.O
92.15%
+6.32%
IKNA.O
92.08%
+7.52%
NUWE.O
91.87%
-32.63%
OCUL.O
91.72%
-28.45%
IPM.O
91.57%
-15.38%
BLTE Seasonality Analysis
Based on BLTE's historical stock price data across all years, the probability of a positive return in July is100.00%, suggesting it maybe an ideal month to invest in BLTE. In contrast,Julyoffers the highest probability of positive returns at100.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Belite Bio Inc (BLTE.O) stock in July has the highest probability of a positive return (100.00%), while January has the lowest probability (0.00%).
Performance Seasonality
The chart shows Belite Bio Inc. (BLTE)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch
FAQ
Should I buy Belite Bio Inc (BLTE.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. BLTE has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
Which months have the highest win rate for buying Belite Bio Inc (BLTE.O) stock in a year?
The radar chart shows that buying Belite Bio Inc (BLTE.O) stock in July has the highest probability of a positive return (100.00%), while January has the lowest probability (0.00%).
How has Belite Bio Inc. (BLTE)'s stock price performed over the past three years?
BLTE's stock price rose by 53.52% in 2023,increased by 47.57% in 2024, and went down by 9.47%in 2025.
Is BLTE a buy based on overall technical signals summary?
BLTE has 0 buy signals and 4 sell signals now. Overall the technical rating for BLTE is Strong sell . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of BLTE.
What is the trend of Belite Bio Inc (BLTE)'s moving average?
Belite Bio Inc's overall moving average trend leans more bearish as of July 08 2025, with 3 negative signals and 1 positive signal.
What is price prediction for BLTE stock next month?
The price prediction chart for Belite Bio Inc (BLTE.O) stock, as of July 06 2025, forecasts a 2.58% change over the next month, based on its high correlation with MFH stock patterns. The similarity between their price movements over the analyzed periods is 94.4%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for BLTE Stock?
The price prediction for BLTE stock in 2025 is expected to reach **$67 to $70**. This forecast is based on the stock's current technical indicators, such as the RSI hovering around 39-46, suggesting potential undervaluation, and the MACD showing a bullish signal. Additionally, the recent FDA Breakthrough Therapy Designation for Tinlarebant has driven positive momentum, with the stock already rising 11.1%. The Fibonacci resistance levels at 65.52 and 67.04 further support this target range.
What is price prediction 2030 for BLTE Stock?
BLTE stock is predicted to reach **$120 by 2030** due to its strong progress in clinical trials and FDA designations, with a potential upside driven by its innovative pipeline. The stock could also reach **$80** if market conditions remain stable.